306 related articles for article (PubMed ID: 6914196)
1. The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin.
Holmer E; Kurachi K; Söderström G
Biochem J; 1981 Feb; 193(2):395-400. PubMed ID: 6914196
[TBL] [Abstract][Full Text] [Related]
2. Mapping the active sites of bovine thrombin, factor IXa, factor Xa, factor XIa, factor XIIa, plasma kallikrein, and trypsin with amino acid and peptide thioesters: development of new sensitive substrates.
McRae BJ; Kurachi K; Heimark RL; Fujikawa K; Davie EW; Powers JC
Biochemistry; 1981 Dec; 20(25):7196-206. PubMed ID: 6976185
[TBL] [Abstract][Full Text] [Related]
3. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin on the inhibition of the contact system enzymes.
Colman RW; Scott CF; Pixley RA; de la Cadena RA
Ann N Y Acad Sci; 1989; 556():95-103. PubMed ID: 2786690
[TBL] [Abstract][Full Text] [Related]
5. Formation of the fibrin clot: the balance of procoagulant and inhibitory factors.
Lämmle B; Griffin JH
Clin Haematol; 1985 Jun; 14(2):281-342. PubMed ID: 2994929
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacology of heparin].
Hoffmann A; Markwardt F
Z Gesamte Inn Med; 1979 Jan; 34(1):3-8. PubMed ID: 373277
[TBL] [Abstract][Full Text] [Related]
7. Effect of heparin on the inactivation rate of human factor XIa by antithrombin-III.
Scott CF; Schapira M; Colman RW
Blood; 1982 Oct; 60(4):940-7. PubMed ID: 7115961
[TBL] [Abstract][Full Text] [Related]
8. Evidence for a plasma inhibitor of the heparin accelerated inhibition of factor Xa by antithrombin III.
MacGregor IR; Lane DA; Kakkar VV
Biochim Biophys Acta; 1979 Sep; 586(3):584-93. PubMed ID: 476156
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of factor IXa and factor Xa by antithrombin III/heparin during factor X activation.
Pieters J; Willems G; Hemker HC; Lindhout T
J Biol Chem; 1988 Oct; 263(30):15313-8. PubMed ID: 3262615
[TBL] [Abstract][Full Text] [Related]
10. Effects of heparin fractions of different affinities to antithrombin III and thrombin on the inactivation of thrombin and factor Xa by antithrombin III.
Cerskus AL; Birchall KJ; Ofosu FA; Hirsh J; Blajchman MA
Can J Biochem Cell Biol; 1984 Oct; 62(10):975-83. PubMed ID: 6509363
[TBL] [Abstract][Full Text] [Related]
11. Factors influencing the acceleration of human factor XIa inactivation by antithrombin III.
Scott CF; Colman RW
Blood; 1989 May; 73(7):1873-9. PubMed ID: 2785417
[TBL] [Abstract][Full Text] [Related]
12. Effect of heparin on the inactivation rate of human activated factor XII by antithrombin III.
Pixley RA; Schapira M; Colman RW
Blood; 1985 Jul; 66(1):198-203. PubMed ID: 3873967
[TBL] [Abstract][Full Text] [Related]
13. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
[TBL] [Abstract][Full Text] [Related]
14. Role of heparin and heparinlike molecules in thrombosis and atherosclerosis.
Rosenberg RD
Fed Proc; 1985 Feb; 44(2):404-9. PubMed ID: 3155697
[TBL] [Abstract][Full Text] [Related]
15. Thrombin activates factor XI on activated platelets in the absence of factor XII.
Oliver JA; Monroe DM; Roberts HR; Hoffman M
Arterioscler Thromb Vasc Biol; 1999 Jan; 19(1):170-7. PubMed ID: 9888880
[TBL] [Abstract][Full Text] [Related]
16. The relative molecular mass dependence of the anti-factor Xa properties of heparin.
Ellis V; Scully MF; Kakkar VV
Biochem J; 1986 Sep; 238(2):329-33. PubMed ID: 3800942
[TBL] [Abstract][Full Text] [Related]
17. Chemistry of the hemostatic mechanism and its relationship to the action of heparin.
Rosenberg RD
Fed Proc; 1977 Jan; 36(1):10-8. PubMed ID: 63388
[No Abstract] [Full Text] [Related]
18. On the molecular-weight-dependence of the anticoagulant activity of heparin.
Thunberg L; Lindahl U; Tengblad A; Laurent TC; Jackson CM
Biochem J; 1979 Jul; 181(1):241-43. PubMed ID: 486155
[TBL] [Abstract][Full Text] [Related]
19. Contribution of exosite occupancy by heparin to the regulation of coagulation proteases by antithrombin.
Yang L; Manithody C; Qureshi SH; Rezaie AR
Thromb Haemost; 2010 Feb; 103(2):277-83. PubMed ID: 20024502
[TBL] [Abstract][Full Text] [Related]
20. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
